Evidence map›Paper›PMID 42860493›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Spatial Au

Zhongren Xu, Zhiyue Fan, Lin Lv, Wei Lu, Zhenfan Wen, Wukun Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhongren Xu *Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Zhiyue Fan *Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Lin Lv *Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Wei LuJiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Zhenfan WenJiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Wukun LiuJiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.ORCID https://orcid.org/0000-0002-0469-907X

Funding

Basic Research Program of Jiangsu BK20250774National Administration of Traditional Chinese Medicine-Resource Chemistry of Chinese Medicinal Materials zyyzdxk-2023083National Natural Science Foundation of China 22507059National Natural Science Foundation of China 82574248Yunnan Provincial Science, and Technology Talent and Platform Program 202405AF140031
6 · The paper itself

Abstract

Although many metal complexes exhibit promising chemoimmunotherapeutic effects by inducing immunogenic cell death (ICD), the precise regulation of how these complexes interact with immune cells remains unclear. Herein, we introduced Au9 as the first representative gold complex to directly associate with immune cells in the tumor immune microenvironment (TIME). Our study delineated the mechanism underlying Au9-driven anti-tumor response and "hot" TIME remodeling, anchored in Au

Indexed as

bis‐N‐heterocyclic carbene Au(I) complexchemoimmunotherapeuticferroptosisimmunogenic cell death

Identifiers

PMID42860493
PMCPMC13654858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.